Clinical Trial Update: Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on pulsed dye laser plus oxymetazoline 1% cream for erythematotelangiectatic rosacea; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythematotelangiectatic Rosacea

Drugs mentioned

• Oxymetazoline Hydrochloride 1% Cream (Oxymetazoline hydrochloride)
• Pulsed Dye Laser

Snippet

Sponsor: Candela Corporation | Conditions: Erythematotelangiectatic Rosacea | Phase 4 | Status: COMPLETED | Results posted: 2022-03-18